Specify a stock or a cryptocurrency in the search bar to get a summary
KPC Pharmaceuticals Inc
600422KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People's Republic of China and internationally. It offers artemisia annua series, panax notoginseng, gastrodia, specialty herbal, fine Chinese, and classic prescription for bones and joint, antibiotic, immunosuppressive, and others. The company provides medicine and food, skin care, oral care, private care, and time-honored food series; and other products, such as oral medication and injections. It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. The company was founded in 1951 and is based in Kunming, the People's Republic of China. Address: No.166 Keyi Road, Kunming, China, 650106
Analytics
WallStreet Target Price
171.92 CNYP/E ratio
26.6949Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 600422
Dividend Analytics 600422
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
33 %Dividend History 600422
Stock Valuation 600422
Financials 600422
Results | 2019 | Dynamics |